Nutraceutical Excipients Market

[391 Pages Report] According to MarketsandMarkets, the nutraceutical excipients market is projected to reach USD 6.1 billion by 2028 from USD 4.2 billion by 2023, at a CAGR of 7.7% during the forecast period in terms of value. Increased focus on preventive care and consumption of supplements has led to a rising demand for nutraceutical excipients.   Innovations in processing technologies are leading to the creation of excipients with improved characteristics. Techniques such as spray drying, freeze-drying, and granulation are enabling the production of excipients with better flowability, compressibility, and consistency.

To know about the assumptions considered for the study, Request for Free Sample Report

To know about the assumptions considered for the study, download the pdf brochure

Market Dynamics

Driver:Advancements in nanotechnology have brought forth a myriad of innovative features that are poised to significantly propel the growth of the nutraceutical excipients market

Advancements in nanotechnology have introduced a multitude of innovative features poised to drive substantial growth within the nutraceutical excipients market. Operating at the nanoscale level, nanotechnology offers distinct and advantageous functionalities for the development of excipients in the nutraceutical industry. Nano-sized excipients play a pivotal role in enhancing the solubility and bioavailability of active ingredients, facilitating superior absorption and utilization of nutrients in the body, thereby amplifying the effectiveness of nutraceutical products. Moreover, excipients at the nanoscale offer increased stability for delicate nutrients, safeguarding them from degradation and extending the shelf life of nutraceuticals, ensuring their efficacy over prolonged periods. Additionally, nanotechnology enables the creation of targeted delivery systems, allowing precise and specific delivery of nutrients to targeted body tissues or cells, thereby optimizing the efficacy of nutraceuticals while minimizing potential adverse effects.

Restraint :Financial hurdles in nutraceutical excipient innovation

Progressing in the nutraceutical industry mandates crucial R&D investments for pioneering excipient innovations. However, achieving lucrative returns on these investments might diminish owing to challenges in securing patents or contending with formidable competition from existing products, potentially reducing profitability. Nutraceutical excipients, akin to pharmaceuticals, necessitate comprehensive clinical trials to establish safety, efficacy, and compliance with regulatory norms. These trials encompass significant expenses, influencing the overall cost structure of bringing a product to market. Moreover, the intricate and protracted nature of these trials can further escalate expenses. Despite considerable R&D and clinical trial investments, product success remains uncertain. Safety concerns, efficacy issues, or lack of market acceptance can lead to substantial financial losses for companies.

The substantial costs linked to clinical trials, in tandem with regulatory intricacies, pose entry barriers for new entrants in the nutraceutical excipients market. This impedes the introduction of innovative excipients, restraining market expansion.

Opportunity : Emerging trend of high use of excipients with multifunctional properties among key players

The utilization of excipients possessing multifunctional properties presents a significant opportunity in the nutraceutical industry. By consolidating numerous functionalities within a single ingredient, these excipients streamline the formulation process, boosting operational efficiency, and reducing the complexity of formulations. This consolidation not only decreases the number of required excipients but also curtails production costs. Moreover, their diverse capabilities, ranging from enhancing stability and solubility to controlling release and masking unwanted tastes or odors, enable the creation of top-tier nutraceutical products with optimized performance. Furthermore, the multifaceted benefits offered by these excipients align with sustainability goals, reducing waste and energy consumption while supporting clean label trends by enabling formulations with fewer, often natural, ingredients. Overall, the adoption of multifunctional excipients represents a strategic avenue for industry players to enhance efficiency, bolster product quality, foster innovation, and cater to evolving consumer preferences, thereby presenting a considerable opportunity for advancement and growth within the nutraceutical excipients market.

Challenge: Protecting intellectual property in nutraceutical excipient development can be a challenge

The fiercely competitive environment within the nutraceutical excipients market presents difficulties in preserving exclusivity. Rival companies often endeavor to create analogous excipients or find ways to bypass existing patents, resulting in potential disputes or violations. Crafting excipients with distinct functionalities or precise delivery mechanisms necessitates inventive strategies. However, formulating patents to encompass these innovations in a manner that safeguards them against replication while complying with patent laws can be intricate. Additionally, the duration of patents is finite, and the arduous and costly processes required to sustain their validity pose challenges. Once patents expire, excipient formulations become vulnerable to competition from generic or akin products.

Nutraceutical Excipients Market Ecosystem

Key players within this market consist of reputable and financially robust nutraceutical excipient manufacturers. These entities boast extensive industry tenure, offering diversified product portfolios, cutting-edge technologies, and robust global sales and marketing networks. Prominent companies in this market include International Flavors & Fragrances Inc (US), Kerry Group plc (Ireland), Ingredion (US), Sensient Technologies Corporation (US), Associated British Foods plc (UK), BASF SE (Germany), Roquette Frères (France), MEGGLE GmbH & Co. KG (Germany), Cargill, Incorporated (US), Ashland (US), IMCD (Netherlands), Hilmar Cheese Company, Inc (US), Air Liquide (France), Azelis Group (Luxembourg), and Biogrund GmbH (Germany).

Taste masking excipients act as catalysts for consumer-friendly nutraceuticals.

Nutraceutical products often contain active ingredients with disagreeable tastes or odors. Taste masking excipients serve as pivotal components in elevating palatability, making these items more appealing and user-friendly, particularly for individuals sensitive to specific flavors. The increasing demand for nutraceutical supplements and functional foods in daily health routines has led to the adoption of taste-masking excipients. These aids enhance product likeability, encouraging consistent usage and adherence to prescribed dosages. Taste-related difficulties frequently affect nutritional supplements intended for children and the elderly. Taste masking excipients facilitate customized formulations tailored to these groups, ensuring improved adherence and consumption rates.

In a competitive market landscape, companies aim to distinguish their offerings. Utilizing taste masking excipients allows manufacturers to set themselves apart by delivering superior-tasting options, differentiating their products from competitors.

The Fillers & Diluents segment is expected to hold the second largest market share in the functionality segment of nutraceutical excipients market.

Fillers & diluents are integral for providing bulk to formulations and ensuring consistent dosages. Their primary role involves creating uniform tablet sizes, facilitating streamlined manufacturing processes, and ensuring even distribution of nutrients. Certain fillers & diluents are specially designed to aid in tablet or capsule disintegration and dissolution, ensuring efficient breakdown in the digestive system for optimal nutrient absorption. They also improve the flow characteristics of formulations, binding ingredients, reducing powder segregation, and enhancing compaction properties during production. Consequently, the fillers & diluents segment is anticipated to play a significant role in the functionality segment of nutraceutical excipients.

North America to dominate the nutraceutical excipients market during the forecast period.

North America is expected to dominate the nutraceutical excipients market during the forecast period from 2023 to 2028 due to several factors. North America's mature nutraceutical market, complemented by its robust pharmaceutical and nutraceutical industries, forms a strong platform for excipient innovation. Renowned for pioneering advancements, the region continually invests in R&D, crafting cutting-edge excipients with superior functionality, improved bioavailability, and precise nutrient delivery. This ongoing commitment to innovation positions North America at the forefront, alluring global industry players. The region boasts a well-established retail infrastructure, offering easy access to nutraceuticals through diverse distribution channels like online platforms, specialty outlets, and conventional supermarkets, fostering nutraceutical excipients market expansion.

Key Market Players

The key players in this include International Flavors & Fragrances Inc (US), Kerry Group plc (Ireland), Ingredion (US), Sensient Technologies Corporation (US), Associated British Foods plc (UK), BASF SE (Germany), Roquette Frères (France), MEGGLE GmbH & Co. KG (Germany), Cargill, Incorporated (US), Ashland (US), IMCD (Netherlands), Hilmar Cheese Company, Inc (US), Air Liquide (France), Azelis Group (Luxembourg), and Biogrund GmbH (Germany). These market participants are emphasizing the expansion of their footprint via agreements and partnerships. They maintain a robust presence in North America, Asia Pacific, and Europe, supported by manufacturing facilities and well-established distribution networks spanning across these regions.

Want to explore hidden markets that can drive new revenue in Nutraceutical Excipients Market?

Unlock Insights

Scope of the Report

This research report categorizes the nutraceutical excipients market, based on functionality, product source, functionality application, end product, formulation, and region.

Target Audience

• Nutraceutical excipient traders, retailers, and distributors
• Nutraceutical excipient manufacturers & suppliers
• Related government authorities, commercial research & development (R&D) institutions, FDA, EFSA, USDA government agencies & NGOs, and other regulatory bodies
• Regulatory bodies, including government agencies and NGOs.
• Commercial research & development (R&D) institutions and financial institutions
• Government and research organizations
• Venture capitalists and investors
• Technology providers to nutraceutical excipients and nutraceutical excipients companies
• Associations and industry bodies

Nutraceutical Excipients Market:

By Product Source

• Organic Chemicals
• Inorganic Chemicals
• Other Chemicals

By Functionality

• Fillers & Diluents
• Suspending & Viscosity Agents
• Coating Agents
• Binders
• Flavoring Agents & Sweeteners
• Disintegrants
• Colorants
• Lubricants & Glidants
• Preservatives
• Emulsifying Agents
• Other Functionalities

By Formulation

• Dry
  • Tablets
  • Capsules
• Liquid
• Other Formulations

By Functionality Application

• Taste Masking
• Stabilizers
• Modified-Release
• Solubility & Bioavailability
• Others

By End Product

• Protein & Amino Acids
• Omega-3 Fatty Acids
• Vitamins
• Minerals
• Prebiotics
• Probiotics
• Other End Products

By Region:

• North America
• South America
• Europe
• Asia Pacific
• Rest of the World (RoW)

Recent Developments

• In September 2022, Roquette, renowned for its expertise in plant-based ingredients and its prominent position as a supplier of pharmaceutical and nutraceutical excipients, finalized the acquisition of Crest Cellulose, an excipient manufacturer based in India. Building upon its prior acquisition of a majority stake in 2018, this recent development underscores Roquette's commitment to advancing its robust expansion goals and addressing the increasing worldwide need for top-tier plant-based excipients. This strategic move aligns with Roquette's endeavors to meet the escalating global demand for high-quality excipients derived from plant sources.
• In February 2021, IFF finalized the merger with DuPont's Nutrition & Biosciences (N&B) division, creating a dominant force in the global ingredients and solutions sector. This amalgamation establishes a leader serving consumer-focused markets such as food & beverage, home & personal care, and health & wellness. Additionally, IFF now offers excipients obtained through the acquisition of DuPont's Nutrition & Biosciences business.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst